Torpedo Pharmaceuticals AG

What an incredible experience at #JPMWeek2025 in San Francisco! We were thrilled to participate in the back-to-back panels and networking event, "Navigating the Funding Landscape for Health Science #Startups", organized by EisnerAmper. Our CEO, Dr. Vladimir Cmiljanovic, was privileged to speak on a panel focused on the diverse world of alternative #funding sources, sharing valuable insights on how life sciences and healthcare startups can secure crucial support without diluting equity. A heartfelt thank you to the event organizers, sponsors, and all the participants. We’re thankful for the opportunity to learn, exchange ideas, and connect with so many passionate individuals in the healthcare and life sciences community. #JPMWeek2025 #LifeSciences #HealthcareInnovation #StartupFunding #Networking

Our CEO, Dr. Vladimir Cmiljanovic, will attend the Biotech Showcase 2025 in San Francisco, CA, from January 13 to 15. Feel free to reach out to discover more about our company's innovative projects and explore potential partnering opportunities. #BiotechShowcase2025 #Biotech #Innovation #LifeSciences #PartneringOpportunities #BiotechIndustry #SanFrancisco2025 #BiotechNetworking

Dr. Vladimir Cmiljanovic, our CEO, will attend the Biotech Showcase 2025 in San Francisco, CA, from January 13 to 15. We invite you to reach out and learn more about our innovative projects and explore potential partnership opportunities. #BiotechShowcase2025 #Biotech #Innovation #LifeSciences #PartneringOpportunities #BiotechIndustry #SanFrancisco2025 #BiotechNetworking

We are excited to announce that Swiss Rockets AG will participate in the 2025 J.P. Morgan Healthcare Conference & Biotech Showcase™ in San Francisco! Our CEO, Dr. Vladimir Cmiljanovic, and CFO & CBO, Andreas Emmenegger, will be on-site to showcase our innovative projects, connect with industry leaders, and celebrate scientific collaboration. We are eager to meet professionals interested in exploring partnerships and collaborative opportunities. Reach out to us — we look forward to seeing you there! contact@swissrockets.com #JPM2025 #BiotechShowcase #HealthcareInnovation #SwissRockets

Happy Holidays and a prosperous New Year to all! May the year ahead bring new achievements, growth, and opportunities. Thank you for your ongoing support and partnership. We look forward to continuing our collaboration in 2025! #HappyHolidays #SeasonGreetings #NewYear2025 #HolidaySeason #TorpedoPharmaceuticals Dr. Vladimir Cmiljanovic Natasa Cmiljanovic, PhD Nadezda Gracheva Andreas Türler Richard P. Baum Vladan Vuletic Bruno Osterwalder Doriano Fabbro Milan Crnogorac Aurélie Jenn David Allman Dirk Mossmann Helene Muller Debora Foglia Jeanette Wood Dr. Thomas Ladner Elcin Zan, MD Ralph Wirtz Vladan Vuletic Vera Artiko Marija Stanisavljevic

We are proud to share the inspiring story of Marija Stanisavljevic, a remarkable team member whose strength and dedication aim to make a real difference in the lives of children with cancer. A distinguished economist with extensive experience in leadership and operations, Marija plays a key role at Swiss Rockets AG, where she supports the executive team and drives initiatives that make a tangible impact in pediatric oncology. But it's her deeply personal journey that truly fuels her incredible work. After the heartbreaking loss of her son Viktor, who bravely fought cancer, Marija channeled her grief into a mission to support other children battling this devastating disease. Don't miss this inspiring interview and learn more about Marija's mission. Marija Stanisavljevic Dr. Vladimir Cmiljanovic Natasa Cmiljanovic, PhD Nadezda Gracheva Debora Foglia Bruno Osterwalder Richard Hubler Andrijana Adamovic Luka Tomasevic #InspiringChange #LeadershipWithPurpose #MakingADifference #SwissRockets #CancerResearch

Radioligand therapy is poised to become one of the most effective treatment modalities in oncology because it enables targeted tumor control. How does it work, as shown in the video? 1. Radioactive element 2. Linker 3. Cancer-targeting molecule 4. Cancer cell 5. Cancer-specific target protein 6. Specific binding of the radiopharmaceutical to cancer target Backed by rigorous experimental testing, Torpedo's targeted radiopharmaceuticals demonstrate versatile applications across various cancer types, with an initial focus on prostate cancer and solid tumors. Visit www.torpedopharma.com and find out more about our technology. #RadioligandTherapy #RLT #OncologyInnovation #TargetedTherapies #CancerTreatment #PrecisionMedicine #CancerResearch Dr. Vladimir Cmiljanovic Nadezda Gracheva Natasa Cmiljanovic, PhD Andreas Türler Richard P. Baum Vladan Vuletic Bruno Osterwalder Doriano Fabbro Milan Crnogorac David Allman Dirk Mossmann Helene Muller Elcin Zan, MD Ralph Wirtz

We’re thrilled to have participated in the Global Family Office Conference hosted by the Global Family Office Community in Beverly Hills (USA). Our CEO, Dr. Vladimir Cmiljanovic, was honored to share ideas, engage in meaningful discussions, and meet incredible people. We sincerely thank Vahe Vartanian, the Founder & CEO of the Global Family Office Community, and all the exceptional individuals who made this event possible. It was an invaluable experience, and we look forward to seeing everyone again next year in sunny California! Dr. Vladimir Cmiljanovic, Michael Morris, Jordan Mersky, Alyssa Weinberger, Kathleen Tepley, Stacey Korman #GlobalFamilyOffice #BeverlyHills #Networking #FamilyOfficeCommunity #Leadership #SwissRockets #Biotechnology

We’re proud to present the latest video story featuring Dr. Thomas Sander. As a founder of Swiss Rockets AG, Dr. Sander has been the driving force behind every step of our journey. His relentless creativity, expertise, and visionary ideas have shaped Swiss Rockets AG into the innovative and dynamic company we are today. From the beginning, Dr. Sander has set the standard for pushing boundaries and turning bold ideas into reality. We are incredibly proud to have him leading the way. Don’t miss this inspiring video story! #Leadership #Innovation #VisionaryLeadership #SwissRocketsAG #InspiringStories #Biotechnology #SoftwareDevelopment Dr. Vladimir Cmiljanovic Natasa Cmiljanovic, PhD Thomas Staehelin Manuel Ebner André Debrunner Dr. Thomas Ladner Christoph Brutschin Daniel Gutenberg Zeljko Mirkovic PhD

We are truly grateful for the opportunity to connect with so many inspiring professionals at #BIOEurope this year. It was a pleasure showcasing our innovative projects and engaging in productive meetings with industry leaders and investors. We gained valuable insights into the rapidly evolving biotech landscape and are excited to continue advancing alongside our new partners. A heartfelt thank you to everyone who reached out and took the time to meet with us. Until next time, #BIOEurope! Dr. Vladimir Cmiljanovic Nadezda Gracheva Luka Tomasevic Luca Bolliger #BIOEurope #Biotech #Innovation #ScientificCollaboration #Networking